Kristin Seigler
Nurse Practitioner · Richmond, VANPI 1801429329
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,465 of the $6,947 with a category attached, or 78.7%. 29 manufacturers reported payments, led by Boston Scientific at 58.2% of the total. 2025 is the largest year on record at $3,177, more than ten times the $217 reported in 2021. Among nurse practitioner clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $51.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Impulse Dynamics (USA) Inc.$323
- Bayer$305
- Edwards Lifesciences$287
- Kestra Medical Technology Services, Inc.$245
- Novartis$220
- plus $2K from 23 others
What the payments were for
- Travel & lodging$1,41220%
- Food & beverage$5,46579%
- Education$701%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 50 | $4,042 |
| Impulse Dynamics (USA) Inc. | 3 | $323 |
| Bayer | 7 | $305 |
| Edwards Lifesciences | 3 | $287 |
| Kestra Medical Technology Services, Inc. | 5 | $245 |
| Novartis | 16 | $220 |
| Shockwave Medical, Inc | 2 | $207 |
| Novo Nordisk | 7 | $157 |
| AstraZeneca | 2 | $151 |
| Boehringer Ingelheim | 3 | $148 |
| CSL Behring | 1 | $117 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $101 |
| Pfizer | 6 | $95 |
| Atricure, Inc. | 2 | $73 |
| Cardiva Medical, Inc. | 2 | $61 |
| Abiomed | 3 | $52 |
| Actelion Pharmaceuticals US, Inc. | 2 | $50 |
| Stryker | 2 | $50 |
| Johnson & Johnson | 3 | $47 |
| Alnylam Pharmaceuticals Inc. | 2 | $29 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Scpharmaceuticals Inc. | 1 | $22 |
| Teleflex LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Biosense Webster, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$2,174
- OPTIMIZER$407
- WATCHMAN FLX$367
- Kerendia$225
- Assure WCD$188
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$157
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$144
- INGEVITY MRI$139
- Edwards SAPIEN 3 Transcatheter Heart Valve$137
- Watchman$134
- FARXIGA$120
- JARDIANCE$119
- Kcentra$117
How this compares
$6,947 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 136 | $130,387 |
| EntrestoSacubitril/Valsartan | 31 | $29,555 |
| FarxigaDapagliflozin Propanediol | 35 | $28,103 |
| XareltoRivaroxaban | 29 | $22,255 |
| JardianceEmpagliflozin | 17 | $12,299 |
| Flecainide Acetate | 50 | $1,816 |
| Metoprolol Succinate | 152 | $1,236 |
| Amiodarone Hcl | 78 | $1,204 |
| Losartan Potassium | 108 | $1,004 |
| Atorvastatin Calcium | 64 | $718 |
| Amlodipine Besylate | 113 | $713 |
| Bumetanide | 22 | $622 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 25 | $581 |
| Carvedilol | 92 | $555 |
| Valsartan | 33 | $552 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $95 | $130,387136 claims |
| NovartisEntresto | $220 | $29,55531 claims |
| AstraZenecaFarxiga | $151 | $28,10335 claims |
| Johnson & JohnsonXarelto | $47 | $22,25529 claims |
| Boehringer IngelheimJardiance | $148 | $12,29917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Other nurse practitioner in Richmond
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Angelica KubeRichmond$10K
- Kristin CrainRichmond$8K
- Michele CanfieldRichmond$6K
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Ashley CarmenAlexandria$99K
- Rachel AndersonCharlottesville$90K
- Megan FrancisArlington$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.